Who should own remediation decisions for connected medical devices?

How remediation ownership should be split for connected medical devices

Remediation should not sit with a single team if the device crosses safety, clinical operations and security boundaries. Security can identify exposure, validate risk and drive containment, while clinical engineering owns device behaviour, maintenance windows and operational suitability. Procurement, exception handling and retirement need named owners so remediation is not delayed by unclear responsibility.

The practical test is whether the owner can actually change the device state in production. If a team can discover a vulnerable infusion pump but cannot coordinate vendor support, clinical downtime or decommissioning, remediation becomes an assessment exercise rather than a control. Ownership should follow the lifecycle, not just the scan result.

Shared ownership works best when the decision rights are explicit: security decides risk acceptance thresholds, clinical engineering decides device feasibility, and operations or procurement handle vendor and replacement dependencies. For connected devices, that split reduces the chance that a security issue is “known” but left open because nobody owns the operational path to close it.

What breaks when ownership is unclear

connected medical device are especially vulnerable to ownership gaps because they are often deployed for years, live in mixed vendor ecosystems and cannot be treated like ordinary endpoints. A remediation decision can affect patient monitoring, therapy delivery or scheduled care, so delays are not just administrative. They can leave an exploitable condition in place long enough to matter clinically.

When accountability is blurred, teams tend to defer action to each other: security waits for clinical approval, clinical teams wait for vendor guidance, and procurement waits for a formal replacement request. That creates a lifecycle gap where discovery, remediation, exception tracking and retirement are handled by different groups with no single decision owner.

A useful anchor for operational triage is the device’s exploitability and exposure path, including active vulnerability status and remediation deadlines in the CISA Known Exploited Vulnerabilities Catalog. For medical-device programs, the same ownership discipline should also cover inventory, trust establishment and hardening guidance, as outlined in the Medical Device Security Guide and the Device and IoT Identity Guide.

How to make remediation decisions workable in practice

The best ownership model is a decision tree, not a committee. Security should own detection, prioritisation and risk articulation. Clinical engineering should own whether the device can be patched, isolated, reconfigured or safely taken out of service. If a change touches care delivery, the clinical owner must sign off on timing; if it touches procurement or replacement, that owner must be in the loop before the issue is closed.

Exception handling matters just as much as patching. If remediation must wait, the owner should document compensating controls, expiry date, revisit trigger and who can approve extension. That prevents temporary exceptions from becoming permanent risk acceptance. Retirement should be treated as a remediation outcome when the device cannot be safely secured or supported any longer.

Healthcare Identity Security Guide is useful here because medical-device remediation often intersects with shared access, third parties and clinical workstations. The core operational question is not just “is the device vulnerable?” but “who can make the compensating or corrective action happen without disrupting care?”

Risk and Threat Considerations

Unclear remediation ownership creates a control failure, not just an administrative delay. In connected medical environments, that can leave exposed devices online, preserve default or weak trust relationships, and allow known vulnerabilities to remain reachable through the clinical network, vendor channel or maintenance pathway.

Failure mechanism: Discovery, containment, patching, exception approval and retirement are split across teams, so no one closes the loop and the exposure persists beyond the point where it should have been remediated.

Impact: The device may stay exploitable while still supporting patient care, which increases the chance of disruption, misuse or unsafe operational dependence.

Practitioner Guidance

What to verify: Confirm that every connected device has one named remediation owner, one clinical approver for downtime-sensitive changes, and one operational path for vendor coordination or replacement. If any of those are missing, the ownership model is incomplete even if the inventory is accurate.

Decision rule: If the fix requires taking the device out of service, move the decision to the team that can assess clinical impact and schedule safely; if the fix is a configuration or access change, security can lead but still needs clinical engineering to validate device behaviour.

What good looks like: A device issue can move from detection to action without handoff ambiguity, and exceptions expire on a schedule rather than lingering until the next audit.

Practitioner takeaway: For connected medical devices, remediation ownership must follow the device lifecycle and patient-safety impact, not the organisational org chart.

Related resources from NHI Mgmt Group

• Who should own SBOM-based remediation decisions in a medical device programme?
• How should security teams prioritise NHI remediation in cloud environments?
• Who should own access decisions when service management and IAM are connected?
• Who should own authentication visibility and remediation decisions?